GNH USA

Europe — EMA

Ondansetron Aurobindo

Ondansetron, the active ingredient in Ondansetron Aurobindo, is a 5-HT3 receptor antagonist presented as a unknown/unknown for unknown use.

Request sourcing

1
Pack/s

What is Ondansetron?

Ondansetron, the active ingredient in Ondansetron Aurobindo, is a 5-HT3 receptor antagonist presented as a unknown/unknown for unknown use. It treats and prevents nausea and vomiting associated with chemotherapy, radiation therapy, and surgery in adults and children. GNH USA supplies Ondansetron Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

GNH USA supplies Ondansetron Aurobindo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

What is Ondansetron used for?

Ondansetron is a selective 5‑HT3 receptor antagonist used in the management of nausea and vomiting pathways.

- Chemotherapy‑induced nausea and vomiting: Reduces the risk of vomiting and vomiting episodes through ser‑­ by the chemo‑induced serotonin release . -    -   . -  ...

What are the side effects of Ondansetron?

This       …  … … ...

Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Ondansetron
Route
Oral Use
Manufacturer
Aurobindo Pharma (Malta) Limited
Origin
EU

Related products